{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:02:25Z","timestamp":1783530145444,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81301835"],"award-info":[{"award-number":["81301835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.prp.2020.152943","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T20:08:30Z","timestamp":1585253310000},"page":"152943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma"],"prefix":"10.1016","volume":"216","author":[{"given":"Ye","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.152943_bib0005","doi-asserted-by":"crossref","first-page":"13238","DOI":"10.1038\/srep13238","article-title":"Clinicopathological significance and potential drug target of CDKN2A\/p16 in endometrial carcinoma","volume":"5","author":"Su","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2020.152943_bib0010","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2020.152943_bib0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2020.152943_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: Multiple Functions in Human Malignant Tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2020.152943_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects","volume":"19","author":"Lee","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081076","article-title":"PTEN Tumor-Suppressor: The Dam of Stemness in Cancer","volume":"11","author":"Luongo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2020.152943_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.152943_bib0045","article-title":"Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.152943_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2004.12.006","article-title":"Genetic mutual relationship between PTEN and p53 in gastric cancer","volume":"227","author":"Oki","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2020.152943_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2020.152943_bib0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2020.152943_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11515-017-1443-5","article-title":"PTEN at the interface of immune tolerance and tumor suppression","volume":"12","author":"Brandmaier","year":"2017","journal-title":"Front. Biol. (Beijing)"},{"key":"10.1016\/j.prp.2020.152943_bib0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036996","article-title":"The role of PTEN in innate and adaptive immunity","author":"Taylor","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.prp.2020.152943_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to t cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2020.152943_bib0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2020.152943_bib0085","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1164918","article-title":"Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition","volume":"5","author":"Kuttke","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2020.152943_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-43139-0_1","article-title":"Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences","volume":"943","author":"Felix","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0100","first-page":"2464","article-title":"Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2020.152943_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.prp.2020.152943_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/ol.2013.1331","article-title":"PTEN mutation, methylation and expression in breast cancer patients","volume":"6","author":"Zhang","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2020.152943_bib0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ng.556","article-title":"Subtle variations in Pten dose determine cancer susceptibility","volume":"42","author":"Alimonti","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2020.152943_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091401","article-title":"Prognostic and predictive implications of PTEN in breast Cancer: unfulfilled promises but intriguing perspectives","volume":"11","author":"Carbognin","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2020.152943_bib0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cjp2.18","article-title":"In-depth molecular profiling of the biphasic components of uterine carcinosarcomas","volume":"1","author":"McConechy","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.prp.2020.152943_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"N. Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.152943_bib0135","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","article-title":"Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN","volume":"20","author":"Nakamura","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0140","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","article-title":"PTEN signaling pathways in melanoma","volume":"22","author":"Wu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2020.152943_bib0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","article-title":"PTEN level in tumor suppression: how much is too little?","volume":"71","author":"Carracedo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0150","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1128\/MCB.00310-08","article-title":"PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression","volume":"28","author":"Chang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2020.152943_bib0155","first-page":"4736","article-title":"PTEN\/MMAC1 mutations in endometrial cancers","volume":"57","author":"Risinger","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0160","first-page":"2500","article-title":"Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias","volume":"58","author":"Maxwell","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0165","first-page":"2095","article-title":"Frequent PTEN\/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors","volume":"58","author":"Obata","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0170","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00404-019-05123-x","article-title":"PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis","volume":"299","author":"Raffone","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prp.2020.152943_bib0175","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2013.455","article-title":"Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas","volume":"109","author":"Akiyama-Abe","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2020.152943_bib0180","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.molonc.2015.04.014","article-title":"PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients","volume":"9","author":"Westin","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2020.152943_bib0185","first-page":"3005","article-title":"PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics","volume":"4","author":"Risinger","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007630","article-title":"The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten","volume":"14","author":"Liang","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2020.152943_bib0195","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-18-1351","article-title":"Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy","volume":"78","author":"Munn","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2020.152943_bib0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500845","article-title":"The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment","volume":"1","author":"Sharma","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.prp.2020.152943_bib0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.prp.2020.152943_bib0210","first-page":"156","article-title":"Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: a review","volume":"4","author":"Raiha","year":"2018","journal-title":"Chronic Dis. Transl. Med."},{"key":"10.1016\/j.prp.2020.152943_bib0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15384047.2014.1002353","article-title":"PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism","volume":"16","author":"Li","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2020.152943_bib0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2017.01.005","article-title":"The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis","volume":"317","author":"Cheng","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.prp.2020.152943_bib0225","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2017.01327","article-title":"miR-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages","volume":"8","author":"Huang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2020.152943_bib0230","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3Kgamma to promote pancreatic Cancer metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820300972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820300972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:43:01Z","timestamp":1759732981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820300972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0344033820300972"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.152943","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.152943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152943"}}